Literature DB >> 10771484

FRAP DNA-dependent protein kinase mediates a late signal transduced from ultraviolet-induced DNA damage.

D B Yarosh1, P D Cruz, I Dougherty, N Bizios, J Kibitel, K Goodtzova, D Both, S Goldfarb, B Green, D Brown.   

Abstract

Ultraviolet radiation induces signal transduction at both early (<6 h) and late (>6 h) times after exposure. The inflammatory and immunosuppressive cytokine tumor necrosis factor alpha is induced at late times, and is induced by ultraviolet-induced DNA damage, as defects in DNA repair increase, and enhanced photoproduct repair reduces, tumor necrosis factor alpha expression. Here we show that late tumor necrosis factor alpha gene expression is sensitive to rapamycin, implicating FKBP12-rapamycin-associated protein, a member of the DNA protein kinase family, as a signal transducer of ultraviolet-induced DNA damage. FKBP12-rapamycin-associated protein was localized in the nucleus of keratinocytes and its level was increased following ultraviolet irradiation. Immuno- precipitated FKBP12-rapamycin-associated protein was stimulated by ultraviolet-irradiated DNA to phosphorylate p53 in vitro, and in vivo rapamycin reduced ultraviolet induction of p53 by 20%. Rapamycin further inhibited the ultraviolet-induced phosphorylation of the FKBP12-rapamycin-associated protein downstream target kinase p70S6K. In mice, topical application of rapamycin before ultraviolet exposure protected against suppression of the contact hypersensitivity that is a hallmark of ultraviolet-induced cytokine gene expression. These results demonstrate that the FKBP12-rapamycin-associated DNA protein kinase transduces the signal of ultraviolet-induced DNA damage into production of immunosuppressive cytokines at late times after ultraviolet irradiation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10771484     DOI: 10.1046/j.1523-1747.2000.00964.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  7 in total

1.  Transcriptional regulation of the mdm2 oncogene by p53 requires TRRAP acetyltransferase complexes.

Authors:  Penny G Ard; Chandrima Chatterjee; Sudeesha Kunjibettu; Leon R Adside; Lisa E Gralinski; Steven B McMahon
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

2.  Murine coronavirus nonstructural protein p28 arrests cell cycle in G0/G1 phase.

Authors:  Chun-Jen Chen; Kazuo Sugiyama; Hideyuki Kubo; Cheng Huang; Shinji Makino
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

3.  Activation of protein kinase CK2 is an early step in the ultraviolet B-mediated increase in interstitial collagenase (matrix metalloproteinase-1; MMP-1) and stromelysin-1 (MMP-3) protein levels in human dermal fibroblasts.

Authors:  Peter Brenneisen; Meinhard Wlaschek; Edith Schwamborn; Lars-Alexander Schneider; Wenjian Ma; Helmut Sies; Karin Scharffetter-Kochanek
Journal:  Biochem J       Date:  2002-07-01       Impact factor: 3.857

4.  Frap, FKBP12 rapamycin-associated protein, is a candidate gene for the plasmacytoma resistance locus Pctr2 and can act as a tumor suppressor gene.

Authors:  Valery Bliskovsky; Edward S Ramsay; John Scott; Wendy DuBois; Wei Shi; Shuling Zhang; Xiaolan Qian; Douglas R Lowy; Beverly A Mock
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-21       Impact factor: 11.205

5.  Rapamycin inhibits yeast nucleotide excision repair independently of tor kinases.

Authors:  Melvin V Limson; Kevin S Sweder
Journal:  Toxicol Sci       Date:  2009-10-05       Impact factor: 4.849

6.  Irradiance-dependent UVB Photocarcinogenesis.

Authors:  Cheng-Che E Lan; Ching-Shuang Wu; Shu-Mei Huang; Chin-Han Wu; Hsiao-Chi Lai; Yu-Ting Peng; Pao-Sheng Hou; Hui-Jun Yang; Gwo-Shing Chen
Journal:  Sci Rep       Date:  2016-11-21       Impact factor: 4.379

7.  Human immunodeficiency virus 1 envelope glycoprotein complex-induced apoptosis involves mammalian target of rapamycin/FKBP12-rapamycin-associated protein-mediated p53 phosphorylation.

Authors:  M Castedo; K F Ferri; J Blanco; T Roumier; N Larochette; J Barretina; A Amendola; R Nardacci; D Métivier; J A Este; M Piacentini; G Kroemer
Journal:  J Exp Med       Date:  2001-10-15       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.